Fusion Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Fusion Pharmaceuticals patents 6 in total

Status Patent
Application
Utility: ENDOSIALIN-BINDING ANTIBODY External link
Filling date: 26 Sep 2025 Issue date: 14 Jul 2022
Application
Utility: RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY External link
Filling date: 26 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: MACROCYCLIC CHELATES AND USES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY External link
Filling date: 26 Sep 2025 Issue date: 23 Sep 2021
Application
Utility: RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY External link
Filling date: 26 Sep 2025 Issue date: 23 Sep 2021
Application
Utility: METHODS, COMPOSITIONS, AND KITS FOR TREATMENT OF CANCER External link
Filling date: 26 Sep 2025 Issue date: 1 Oct 2020

Showing 1 to 6 of 6 patents.